mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.002 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |